350 related articles for article (PubMed ID: 26299616)
21. Natural history of merkel cell carcinoma following locoregional recurrence.
Grotz TE; Tarantola TI; Otley CC; Weaver AL; McGree ME; Jakub JW
Ann Surg Oncol; 2012 Aug; 19(8):2556-62. PubMed ID: 22453243
[TBL] [Abstract][Full Text] [Related]
22. Merkel cell carcinoma: high recurrence rate despite aggressive treatment.
Soult MC; Feliberti EC; Silverberg ML; Perry RR
J Surg Res; 2012 Sep; 177(1):75-80. PubMed ID: 22537840
[TBL] [Abstract][Full Text] [Related]
23. Differentiation between merkel cell carcinoma and malignant melanoma: An immunohistochemical study.
Kontochristopoulos GJ; Stavropoulos PG; Krasagakis K; Goerdt S; Zouboulis CC
Dermatology; 2000; 201(2):123-6. PubMed ID: 11053914
[TBL] [Abstract][Full Text] [Related]
24. Organ transplant recipients with Merkel cell carcinoma have reduced progression-free, overall, and disease-specific survival independent of stage at presentation.
Arron ST; Canavan T; Yu SS
J Am Acad Dermatol; 2014 Oct; 71(4):684-90. PubMed ID: 24993599
[TBL] [Abstract][Full Text] [Related]
25. Merkel cell carcinoma: 30-year experience from a single institution.
Santamaria-Barria JA; Boland GM; Yeap BY; Nardi V; Dias-Santagata D; Cusack JC
Ann Surg Oncol; 2013 Apr; 20(4):1365-73. PubMed ID: 23208132
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological characteristics of head and neck Merkel cell carcinomas.
Knopf A; Bas M; Hofauer B; Mansour N; Stark T
Head Neck; 2017 Jan; 39(1):92-97. PubMed ID: 27447124
[TBL] [Abstract][Full Text] [Related]
27. Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.
Johnson PW; Joel SP; Love S; Butcher M; Pandian MR; Squires L; Wrigley PF; Slevin ML
Br J Cancer; 1993 Apr; 67(4):760-6. PubMed ID: 8385978
[TBL] [Abstract][Full Text] [Related]
28. Cytological and Immunocytochemical Features of Merkel Cell Carcinoma on Fine Needle Cytology Samples: A Study of 22 Cases.
Cipolletta Campanile A; Malzone MG; Sanna V; Barizzi J; Manna A; Gioioso A; De Chiara A; Fulciniti F
Endocr Pathol; 2015 Sep; 26(3):243-9. PubMed ID: 25982258
[TBL] [Abstract][Full Text] [Related]
29. Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma.
Smith FO; Yue B; Marzban SS; Walls BL; Carr M; Jackson RS; Puleo CA; Padhya T; Cruse CW; Gonzalez RJ; Sarnaik AA; Schell MJ; DeConti RC; Messina JL; Sondak VK; Zager JS
Cancer; 2015 Sep; 121(18):3252-60. PubMed ID: 26038193
[TBL] [Abstract][Full Text] [Related]
30. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
Baudin E; Gigliotti A; Ducreux M; Ropers J; Comoy E; Sabourin JC; Bidart JM; Cailleux AF; Bonacci R; Ruffié P; Schlumberger M
Br J Cancer; 1998 Oct; 78(8):1102-7. PubMed ID: 9792158
[TBL] [Abstract][Full Text] [Related]
31. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival?
Sandel HD; Day T; Richardson MS; Scarlett M; Gutman KA
Laryngoscope; 2006 May; 116(5):791-5. PubMed ID: 16652089
[TBL] [Abstract][Full Text] [Related]
32. Differential Outcomes Among Immunosuppressed Patients With Merkel Cell Carcinoma: Impact of Immunosuppression Type on Cancer-specific and Overall Survival.
Cook M; Baker K; Redman M; Lachance K; Nguyen MH; Parvathaneni U; Bhatia S; Nghiem P; Tseng YD
Am J Clin Oncol; 2019 Jan; 42(1):82-88. PubMed ID: 30211723
[TBL] [Abstract][Full Text] [Related]
33. High Number of Circulating Tumor Cells Predicts Poor Survival of Cutaneous Melanoma Patients in China.
Li J; Fu W; Zhang W; Li P
Med Sci Monit; 2018 Jan; 24():324-331. PubMed ID: 29337932
[TBL] [Abstract][Full Text] [Related]
34. Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC).
Suárez AL; Louis P; Kitts J; Busam K; Myskowski PL; Wong RJ; Chen CS; Spencer P; Lacouture M; Pulitzer MP
J Am Acad Dermatol; 2015 Dec; 73(6):968-75. PubMed ID: 26433246
[TBL] [Abstract][Full Text] [Related]
35. Predictors of survival and recurrence in the surgical treatment of merkel cell carcinoma of the extremities.
Senchenkov A; Barnes SA; Moran SL
J Surg Oncol; 2007 Mar; 95(3):229-34. PubMed ID: 17323336
[TBL] [Abstract][Full Text] [Related]
36. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
Nisman B; Heching N; Biran H; Barak V; Peretz T
Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245
[TBL] [Abstract][Full Text] [Related]
37. Trisomy 6 in Merkel cell carcinoma: a recurrent chromosomal aberration.
Gancberg D; Feoli F; Hamels J; de Saint-Aubain N; André J; Rouas G; Verhest A; Larsimont D
Histopathology; 2000 Nov; 37(5):445-51. PubMed ID: 11119126
[TBL] [Abstract][Full Text] [Related]
38. [Recent update on tumour biology and treatment of Merkel Cell carcinoma].
Steinstraesser L; Kueckelhaus M; Koljonen V
Handchir Mikrochir Plast Chir; 2011 Dec; 43(6):345-9. PubMed ID: 22241518
[TBL] [Abstract][Full Text] [Related]
39. High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome.
Touzé A; Le Bidre E; Laude H; Fleury MJ; Cazal R; Arnold F; Carlotti A; Maubec E; Aubin F; Avril MF; Rozenberg F; Tognon M; Maruani A; Guyetant S; Lorette G; Coursaget P
J Clin Oncol; 2011 Apr; 29(12):1612-9. PubMed ID: 21422439
[TBL] [Abstract][Full Text] [Related]
40. CD56: a useful marker for diagnosing Merkel cell carcinoma.
Kurokawa M; Nabeshima K; Akiyama Y; Maeda S; Nishida T; Nakayama F; Amano M; Ogata K; Setoyama M
J Dermatol Sci; 2003 May; 31(3):219-24. PubMed ID: 12727026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
